Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...

Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call. My name is Ezra, and I will be your coordinator today. [Operator ...

Q4 2024 Earnings Call Transcript January 31, 2025 W.W. Grainger, Inc. misses on earnings expectations. Reported EPS is $9.71 ...

In a major relief to Apex Laboratories, the Madras High Court has issued a permanent injunction against Macleods ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with ... The primary analysis assessed PPI exposure to women during the 4 weeks prior to conception through ...

Precise, high-quality silicone is essential for medical devices like catheters, surgical tools, prosthetics and long-term ...

Thermo Fisher reported revenue for the quarter grew 5% to $11.40 billion in 2024 versus the same quarter of 2023. Organic ...

As medical devices become smaller and more complex, traditional manufacturing methods struggle to meet the need for precision ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Greetings and welcome to the W.W. Grainger fourth quarter 2024 earnings conference call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

These are additional sums added to your ESA. According to DWP data, there are 23 categories of medical conditions that could potentially make you eligible for ESA. ChronicleLive is now on WhatsApp ...